Global Avanafil (Cas 330784-47-9) Market Professional Survey Report 2017

January 2017 | 127 pages | ID: G790706EF69EN
QYResearch

Abstracts

Notes:

Production, means the output of Avanafil (Cas 330784-47-9)

Revenue, means the sales value of Avanafil (Cas 330784-47-9)

This report studies Avanafil (Cas 330784-47-9) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• VIVUS
• Menarini Group
• Auxilium Pharmaceuticals, Inc
• Sanofi
• Endo International
• JW Pharmaceutical

By types, the market can be split into

• By Dosage
• 50mg
• 100mg
• 200mg
• By Purity
• ≥99%
• Other

By Application, the market can be split into

• Pharmaceutical
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Avanafil (Cas 330784-47-9) Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF AVANAFIL (CAS 330784-47-9)

1.1 Definition and Specifications of Avanafil (Cas 330784-47-9)
  1.1.1 Definition of Avanafil (Cas 330784-47-9)
  1.1.2 Specifications of Avanafil (Cas 330784-47-9)
1.2 Classification of Avanafil (Cas 330784-47-9)
  1.2.1 By Dosage
  1.2.2 50mg
  1.2.3 100mg
  1.2.4 200mg
  1.2.5 By Purity
  1.2.6 ≥99%
  1.2.7 Other
1.3 Applications of Avanafil (Cas 330784-47-9)
  1.3.1 Pharmaceutical
  1.3.2 Other
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF AVANAFIL (CAS 330784-47-9)

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Avanafil (Cas 330784-47-9)
2.3 Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)
2.4 Industry Chain Structure of Avanafil (Cas 330784-47-9)

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF AVANAFIL (CAS 330784-47-9)

3.1 Capacity and Commercial Production Date of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015

4 GLOBAL AVANAFIL (CAS 330784-47-9) OVERALL MARKET OVERVIEW

4.1 2011-2016 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016 Global Avanafil (Cas 330784-47-9) Capacity and Growth Rate Analysis
  4.2.2 2015 Avanafil (Cas 330784-47-9) Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016 Global Avanafil (Cas 330784-47-9) Sales and Growth Rate Analysis
  4.3.2 2015 Avanafil (Cas 330784-47-9) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016 Global Avanafil (Cas 330784-47-9) Sales Price
  4.4.2 2015 Avanafil (Cas 330784-47-9) Sales Price Analysis (Company Segment)

5 AVANAFIL (CAS 330784-47-9) REGIONAL MARKET ANALYSIS

5.1 North America Avanafil (Cas 330784-47-9) Market Analysis
  5.1.1 North America Avanafil (Cas 330784-47-9) Market Overview
  5.1.2 North America 2011-2016 Avanafil (Cas 330784-47-9) Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016 Avanafil (Cas 330784-47-9) Sales Price Analysis
  5.1.4 North America 2015 Avanafil (Cas 330784-47-9) Market Share Analysis
5.2 China Avanafil (Cas 330784-47-9) Market Analysis
  5.2.1 China Avanafil (Cas 330784-47-9) Market Overview
  5.2.2 China 2011-2016 Avanafil (Cas 330784-47-9) Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016 Avanafil (Cas 330784-47-9) Sales Price Analysis
  5.2.4 China 2015 Avanafil (Cas 330784-47-9) Market Share Analysis
5.3 Europe Avanafil (Cas 330784-47-9) Market Analysis
  5.3.1 Europe Avanafil (Cas 330784-47-9) Market Overview
  5.3.2 Europe 2011-2016 Avanafil (Cas 330784-47-9) Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016 Avanafil (Cas 330784-47-9) Sales Price Analysis
  5.3.4 Europe 2015 Avanafil (Cas 330784-47-9) Market Share Analysis
5.4 Southeast Asia Avanafil (Cas 330784-47-9) Market Analysis
  5.4.1 Southeast Asia Avanafil (Cas 330784-47-9) Market Overview
  5.4.2 Southeast Asia 2011-2016 Avanafil (Cas 330784-47-9) Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016 Avanafil (Cas 330784-47-9) Sales Price Analysis
  5.4.4 Southeast Asia 2015 Avanafil (Cas 330784-47-9) Market Share Analysis
5.5 Japan Avanafil (Cas 330784-47-9) Market Analysis
  5.5.1 Japan Avanafil (Cas 330784-47-9) Market Overview
  5.5.2 Japan 2011-2016 Avanafil (Cas 330784-47-9) Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016 Avanafil (Cas 330784-47-9) Sales Price Analysis
  5.5.4 Japan 2015 Avanafil (Cas 330784-47-9) Market Share Analysis
5.6 India Avanafil (Cas 330784-47-9) Market Analysis
  5.6.1 India Avanafil (Cas 330784-47-9) Market Overview
  5.6.2 India 2011-2016 Avanafil (Cas 330784-47-9) Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016 Avanafil (Cas 330784-47-9) Sales Price Analysis
  5.6.4 India 2015 Avanafil (Cas 330784-47-9) Market Share Analysis

6 GLOBAL 2011-2016 AVANAFIL (CAS 330784-47-9) SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016 Avanafil (Cas 330784-47-9) Sales by Type
6.2 Different Types of Avanafil (Cas 330784-47-9) Product Interview Price Analysis
6.3 Different Types of Avanafil (Cas 330784-47-9) Product Driving Factors Analysis
  6.3.1 By Dosage of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  6.3.2 50mg of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  6.3.3 100mg of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  6.3.4 200mg of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  6.3.5 By Purity of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  6.3.6 ≥99% of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  6.3.7 Other of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis

7 GLOBAL 2011-2016 AVANAFIL (CAS 330784-47-9) SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016 Avanafil (Cas 330784-47-9) Consumption by Application
7.2 Different Application of Avanafil (Cas 330784-47-9) Product Interview Price Analysis
7.3 Different Application of Avanafil (Cas 330784-47-9) Product Driving Factors Analysis
  7.3.1 Pharmaceutical of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis
  7.3.2 Other of Avanafil (Cas 330784-47-9) Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF AVANAFIL (CAS 330784-47-9)

8.1 VIVUS
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 By Dosage
    8.1.2.2 50mg
    8.1.2.3 100mg
  8.1.3 VIVUS 2015 Avanafil (Cas 330784-47-9) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 VIVUS 2015 Avanafil (Cas 330784-47-9) Business Region Distribution Analysis
8.2 Menarini Group
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 By Dosage
    8.2.2.2 50mg
    8.2.2.3 100mg
  8.2.3 Menarini Group 2015 Avanafil (Cas 330784-47-9) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Menarini Group 2015 Avanafil (Cas 330784-47-9) Business Region Distribution Analysis
8.3 Auxilium Pharmaceuticals, Inc
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 By Dosage
    8.3.2.2 50mg
    8.3.2.3 100mg
  8.3.3 Auxilium Pharmaceuticals, Inc 2015 Avanafil (Cas 330784-47-9) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Auxilium Pharmaceuticals, Inc 2015 Avanafil (Cas 330784-47-9) Business Region Distribution Analysis
8.4 Sanofi
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 By Dosage
    8.4.2.2 50mg
    8.4.2.3 100mg
  8.4.3 Sanofi 2015 Avanafil (Cas 330784-47-9) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Sanofi 2015 Avanafil (Cas 330784-47-9) Business Region Distribution Analysis
8.5 Endo International
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 By Dosage
    8.5.2.2 50mg
    8.5.2.3 100mg
  8.5.3 Endo International 2015 Avanafil (Cas 330784-47-9) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Endo International 2015 Avanafil (Cas 330784-47-9) Business Region Distribution Analysis
8.6 JW Pharmaceutical
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 By Dosage
    8.6.2.2 50mg
    8.6.2.3 100mg
  8.6.3 JW Pharmaceutical 2015 Avanafil (Cas 330784-47-9) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 JW Pharmaceutical 2015 Avanafil (Cas 330784-47-9) Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF AVANAFIL (CAS 330784-47-9) MARKET

9.1 Global Avanafil (Cas 330784-47-9) Market Trend Analysis
  9.1.1 Global 2016-2021 Avanafil (Cas 330784-47-9) Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Avanafil (Cas 330784-47-9) Sales Price Forecast
9.2 Avanafil (Cas 330784-47-9) Regional Market Trend
  9.2.1 North America 2016-2021 Avanafil (Cas 330784-47-9) Consumption Forecast
  9.2.2 China 2016-2021 Avanafil (Cas 330784-47-9) Consumption Forecast
  9.2.3 Europe 2016-2021 Avanafil (Cas 330784-47-9) Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Avanafil (Cas 330784-47-9) Consumption Forecast
  9.2.5 Japan 2016-2021 Avanafil (Cas 330784-47-9) Consumption Forecast
  9.2.6 India 2016-2021 Avanafil (Cas 330784-47-9) Consumption Forecast
9.3 Avanafil (Cas 330784-47-9) Market Trend (Product Type)
9.4 Avanafil (Cas 330784-47-9) Market Trend (Application)

10 AVANAFIL (CAS 330784-47-9) MARKETING TYPE ANALYSIS

10.1 Avanafil (Cas 330784-47-9) Regional Marketing Type Analysis
10.2 Avanafil (Cas 330784-47-9) International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Avanafil (Cas 330784-47-9) by Regions
10.4 Avanafil (Cas 330784-47-9) Supply Chain Analysis

11 CONSUMERS ANALYSIS OF AVANAFIL (CAS 330784-47-9)

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL AVANAFIL (CAS 330784-47-9) MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Avanafil (Cas 330784-47-9)
Table Product Specifications of Avanafil (Cas 330784-47-9)
Table Classification of Avanafil (Cas 330784-47-9)
Figure Global Production Market Share of Avanafil (Cas 330784-47-9) by Type in 2015
Figure By Dosage Picture
Table Major Manufacturers of By Dosage
Figure 50mg Picture
Table Major Manufacturers of 50mg
Figure 100mg Picture
Table Major Manufacturers of 100mg
Figure 200mg Picture
Table Major Manufacturers of 200mg
Figure By Purity Picture
Table Major Manufacturers of By Purity
Figure ≥99% Picture
Table Major Manufacturers of ≥99%
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Avanafil (Cas 330784-47-9)
Figure Global Consumption Volume Market Share of Avanafil (Cas 330784-47-9) by Application in 2015
Figure Pharmaceutical Examples
Table Major Consumers of Pharmaceutical
Figure Other Examples
Table Major Consumers of Other
Figure Market Share of Avanafil (Cas 330784-47-9) by Regions
Figure North America Avanafil (Cas 330784-47-9) Market Size (2011-2021)
Figure China Avanafil (Cas 330784-47-9) Market Size (2011-2021)
Figure Europe Avanafil (Cas 330784-47-9) Market Size (2011-2021)
Figure Southeast Asia Avanafil (Cas 330784-47-9) Market Size (2011-2021)
Figure Japan Avanafil (Cas 330784-47-9) Market Size (2011-2021)
Figure India Avanafil (Cas 330784-47-9) Market Size (2011-2021)
Table Avanafil (Cas 330784-47-9) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Avanafil (Cas 330784-47-9) in 2015
Figure Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)
Figure Industry Chain Structure of Avanafil (Cas 330784-47-9)
Table Capacity and Commercial Production Date of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Avanafil (Cas 330784-47-9) 2011-2016
Figure Global 2011-2016 Avanafil (Cas 330784-47-9) Market Size (Volume) and Growth Rate
Figure Global 2011-2016 Avanafil (Cas 330784-47-9) Market Size (Value) and Growth Rate
Table 2011-2016 Global Avanafil (Cas 330784-47-9) Capacity and Growth Rate
Table 2015 Global Avanafil (Cas 330784-47-9) Capacity List (Company Segment)
Table 2011-2016 Global Avanafil (Cas 330784-47-9) Sales and Growth Rate
Table 2015 Global Avanafil (Cas 330784-47-9) Sales List (Company Segment)
Table 2011-2016 Global Avanafil (Cas 330784-47-9) Sales Price
Table 2015 Global Avanafil (Cas 330784-47-9) Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Avanafil (Cas 330784-47-9) 2011-2016
Figure North America 2011-2016 Avanafil (Cas 330784-47-9) Sales Price
Figure North America 2015 Avanafil (Cas 330784-47-9) Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Avanafil (Cas 330784-47-9) 2011-2016
Figure China 2011-2016 Avanafil (Cas 330784-47-9) Sales Price
Figure China 2015 Avanafil (Cas 330784-47-9) Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Avanafil (Cas 330784-47-9) 2011-2016
Figure Europe 2011-2016 Avanafil (Cas 330784-47-9) Sales Price
Figure Europe 2015 Avanafil (Cas 330784-47-9) Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Avanafil (Cas 330784-47-9) 2011-2016
Figure Southeast Asia 2011-2016 Avanafil (Cas 330784-47-9) Sales Price
Figure Southeast Asia 2015 Avanafil (Cas 330784-47-9) Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Avanafil (Cas 330784-47-9) 2011-2016
Figure Japan 2011-2016 Avanafil (Cas 330784-47-9) Sales Price
Figure Japan 2015 Avanafil (Cas 330784-47-9) Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Avanafil (Cas 330784-47-9) 2011-2016
Figure India 2011-2016 Avanafil (Cas 330784-47-9) Sales Price
Figure India 2015 Avanafil (Cas 330784-47-9) Sales Market Share
Table Global 2011-2016 Avanafil (Cas 330784-47-9) Sales by Type
Table Different Types Avanafil (Cas 330784-47-9) Product Interview Price
Table Global 2011-2016 Avanafil (Cas 330784-47-9) Sales by Application
Table Different Application Avanafil (Cas 330784-47-9) Product Interview Price
Table VIVUS Information List
Table By Dosage Avanafil (Cas 330784-47-9) Overview
Table 50mg Avanafil (Cas 330784-47-9) Overview
Table 2015 VIVUS Avanafil (Cas 330784-47-9) Revenue, Sales, Ex-factory Price
Figure 2015 VIVUS 2015 Avanafil (Cas 330784-47-9) Business Region Distribution
Table Menarini Group Information List
Table By Dosage Avanafil (Cas 330784-47-9) Overview
Table 50mg Avanafil (Cas 330784-47-9) Overview
Table 2015 Menarini Group Avanafil (Cas 330784-47-9) Revenue, Sales, Ex-factory Price
Figure 2015 Menarini Group 2015 Avanafil (Cas 330784-47-9) Business Region Distribution
Table Auxilium Pharmaceuticals, Inc Information List
Table By Dosage Avanafil (Cas 330784-47-9) Overview
Table 50mg Avanafil (Cas 330784-47-9) Overview
Table 2015 Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Revenue, Sales, Ex-factory Price
Figure 2015 Auxilium Pharmaceuticals, Inc 2015 Avanafil (Cas 330784-47-9) Business Region Distribution
Table Sanofi Information List
Table By Dosage Avanafil (Cas 330784-47-9) Overview
Table 50mg Avanafil (Cas 330784-47-9) Overview
Table 2015 Sanofi Avanafil (Cas 330784-47-9) Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi 2015 Avanafil (Cas 330784-47-9) Business Region Distribution
Table Endo International Information List
Table By Dosage Avanafil (Cas 330784-47-9) Overview
Table 50mg Avanafil (Cas 330784-47-9) Overview
Table 2015 Endo International Avanafil (Cas 330784-47-9) Revenue, Sales, Ex-factory Price
Figure 2015 Endo International 2015 Avanafil (Cas 330784-47-9) Business Region Distribution
Table JW Pharmaceutical Information List
Table By Dosage Avanafil (Cas 330784-47-9) Overview
Table 50mg Avanafil (Cas 330784-47-9) Overview
Table 2015 JW Pharmaceutical Avanafil (Cas 330784-47-9) Revenue, Sales, Ex-factory Price
Figure 2015 JW Pharmaceutical 2015 Avanafil (Cas 330784-47-9) Business Region Distribution
Figure Global 2016-2021 Avanafil (Cas 330784-47-9) Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Avanafil (Cas 330784-47-9) Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Avanafil (Cas 330784-47-9) Sales Price Forecast
Figure North America 2016-2021 Avanafil (Cas 330784-47-9) Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Avanafil (Cas 330784-47-9) Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Avanafil (Cas 330784-47-9) Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Avanafil (Cas 330784-47-9) Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Avanafil (Cas 330784-47-9) Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Avanafil (Cas 330784-47-9) Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Avanafil (Cas 330784-47-9) by Types 2016-2021
Table Global Consumption Volume of Avanafil (Cas 330784-47-9) by Applications 2016-2021
Table Traders or Distributors with Contact Information of Avanafil (Cas 330784-47-9) by Regions